Index Performance
-11.07%
SYNB
Overview
Description
SynBio market (incl. biomedical, bioservices & bioprocess, food & agriculture, industrial bioproducts & ingredients, biotools & reagents) is booming.
- TickerSYNB
- Inception Date01/13/2023
- WeightingMarket Cap
- # of holdings99
What's inside?
Holdings
All holdings as of September 26, 2023
CSV download
| Moderna, Inc. (MRNA) | 20.38% | $37.344B | -92.71% | -138.66% | 3.70x |
| BioNTech SE (BNTX) | 13.81% | $24.754B | -94.63% | 2.86% | 1.13x |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 12.66% | $21.881B | 41.78% | 73.22% | 19.61x |
| BioMarin Pharmaceutical, Inc. (BMRN) | 9.13% | $16.571B | 12.64% | 75.84% | 7.67x |
| Sarepta Therapeutics, Inc. (SRPT) | 6.24% | $11.138B | 11.89% | 82.81% | 9.63x |
| Ionis Pharmaceuticals, Inc. (IONS) | 3.74% | $6.633B | 40.82% | 95.63% | 8.71x |
| Genscript Biotech Corp. (1548) | 2.82% | N/A | 23.34% | 48.60% | 9.38x |
| BridgeBio Pharma, Inc. (BBIO) | 2.43% | $4.319B | -97.77% | -17.98% | 723.08x |
| 10X Genomics, Inc. (TXG) | 2.33% | $4.223B | 28.10% | 61.08% | 10.95x |
| CRISPR Therapeutics AG (CRSP) | 2.06% | $3.662B | 44,203.80% | 29.15% | 17.15x |
| Amicus Therapeutics, Inc. (FOLD) | 1.95% | $3.514B | 17.06% | 88.02% | 11.02x |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 1.64% | $2.808B | -51.18% | 79.30% | 13.52x |
| Intellia Therapeutics, Inc. (NTLA) | 1.60% | $2.863B | -3.11% | 84.04% | 52.99x |
| Ginkgo Bioworks Holdings, Inc. (DNA) | 1.56% | $2.770B | -44.29% | 55.63% | 8.83x |
| Ultragenyx Pharmaceutical, Inc. (RARE) | 1.54% | $2.674B | 21.23% | 90.85% | 9.05x |
| PTC Therapeutics, Inc. (PTCT) | 1.34% | $1.703B | 29.17% | 71.88% | 4.16x |
| Oxford Nanopore Technologies Plc (ONT) | 1.19% | N/A | 48.59% | 56.61% | 8.00x |
| Beam Therapeutics, Inc. (BEAM) | 1.04% | $1.869B | 20.80% | 63.76% | 19.23x |
| Arcellx, Inc. (ACLX) | 0.94% | $1.676B | N/A | 95.12% | 34.40x |
| CureVac NV (CVAC) | 0.93% | $1.648B | -61.53% | -303.85% | 45.77x |
| Twist Bioscience Corp. (TWST) | 0.66% | $1.140B | 13.59% | 34.35% | 3.83x |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 0.66% | $1.206B | -71.61% | 36.19% | 3.77x |
| CanSino Biologics, Inc. (CASBF) | 0.58% | N/A | -100.00% | N/A | 8.10x |
| Iovance Biotherapeutics, Inc. (IOVA) | 0.54% | $1.100B | N/A | -3,243.70% | 5,925.06x |
| Verve Therapeutics, Inc. (VERV) | 0.47% | $0.828B | N/A | -44.58% | 142.89x |
| REGENXBIO, Inc. (RGNX) | 0.43% | $0.755B | -38.81% | 30.37% | 6.62x |
| Sana Biotechnology, Inc. (SANA) | 0.41% | $0.742B | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings, Inc. (ARCT) | 0.41% | $0.711B | -64.70% | N/A | 1.58x |
| Ambrx Biopharma, Inc. (AMAM) | 0.39% | $0.654B | N/A | 8.99% | 93.94x |
| ImmunityBio, Inc. (IBRX) | 0.35% | $0.981B | 17.14% | -15,309.76% | 3,355.35x |
| Editas Medicine, Inc. (EDIT) | 0.32% | $0.576B | -54.62% | 46.66% | 9.97x |
| Allogene Therapeutics, Inc. (ALLO) | 0.32% | $0.563B | -48.84% | -8,520.45% | 1,749.04x |
| 4D Molecular Therapeutics, Inc. (FDMT) | 0.31% | $0.553B | 47.53% | -497.49% | 174.26x |
| Wave Life Sciences Ltd. (WVE) | 0.28% | $0.524B | 5,794.93% | 89.50% | 6.95x |
| Avidity Biosciences, Inc. (RNA) | 0.27% | $0.473B | 6.34% | 45.55% | 22.93x |
| Entrada Therapeutics, Inc. (TRDA) | 0.25% | $0.495B | N/A | 96.15% | 4.57x |
| Caribou Biosciences, Inc. (CRBU) | 0.23% | $0.433B | -10.42% | 70.01% | 2.04x |
| Carbios SA (ALCRB) | 0.21% | N/A | -33.33% | N/A | 4,695.76x |
| Oxford Biomedica Plc (OXB) | 0.20% | N/A | -1.97% | 49.37% | 3.03x |
| Precigen, Inc. (PGEN) | 0.20% | $0.358B | -39.30% | -43.94% | 9.26x |
| Voyager Therapeutics, Inc. (VYGR) | 0.19% | $0.337B | 581.60% | 77.62% | 1.27x |
| bluebird bio, Inc. (BLUE) | 0.18% | $0.329B | 353.59% | -38.81% | 44.42x |
| Arbutus Biopharma Corp. (ABUS) | 0.18% | $0.325B | -67.34% | 92.65% | 10.21x |
| uniQure NV (QURE) | 0.18% | $0.331B | 387.32% | -62.68% | 3.83x |
| MeiraGTx Holdings Plc (MGTX) | 0.17% | $0.308B | -67.10% | 8.28% | 23.27x |
| Calyxt, Inc. (CLXT) | 0.16% | $0.306B | 380.49% | -268.53% | 547.42x |
| Gevo, Inc. (GEVO) | 0.16% | $0.285B | 4,661.80% | -81.64% | 1.29x |
| Generation Bio Co. (GBIO) | 0.13% | $0.243B | N/A | -49.43% | 145.00x |
| Fate Therapeutics, Inc. (FATE) | 0.12% | $0.199B | -94.97% | -378.67% | 1.65x |
| Poseida Therapeutics, Inc. (PSTX) | 0.12% | $0.206B | 641.22% | 92.96% | 0.16x |
| Aemetis, Inc. (AMTX) | 0.10% | $0.171B | -31.55% | 4.34% | 3.64x |
| Adverum Biotechnologies, Inc. (ADVM) | 0.10% | $0.174B | N/A | N/A | 30.53x |
| Atara Biotherapeutics, Inc. (ATRA) | 0.09% | $0.159B | -98.14% | -636.05% | 11.67x |
| Vor Biopharma, Inc. (VOR) | 0.09% | $0.145B | N/A | N/A | N/A |
| 2seventy Bio, Inc. (TSVT) | 0.09% | $0.174B | 167.38% | 81.26% | 3.37x |
| Capricor Therapeutics, Inc. (CAPR) | 0.09% | $0.147B | N/A | 93.66% | 9.40x |
| Graphite Bio, Inc. (GRPH) | 0.08% | $0.144B | N/A | N/A | N/A |
| Absci Corp. (ABSI) | 0.07% | $0.119B | 236.03% | -3.89% | 2.26x |
| PepGen Inc. (PEPG) | 0.07% | $0.120B | N/A | N/A | N/A |
| Agronomics Ltd. (AGNMF) | 0.07% | N/A | 69.29% | N/A | 0.12x |
| Sangamo Therapeutics, Inc. (SGMO) | 0.07% | $0.120B | -76.73% | 37.73% | 0.55x |
| ProQR Therapeutics NV (PRQR) | 0.06% | $0.117B | 20.22% | N/A | 3.68x |
| Codexis, Inc. (CDXS) | 0.06% | $0.105B | -44.48% | 78.16% | 1.39x |
| Abeona Therapeutics, Inc. (ABEO) | 0.06% | $0.100B | 250.00% | 76.06% | 11.62x |
| Cellectis SA (ALCLS) | 0.05% | N/A | -87.09% | -2,410.64% | 6.89x |
| Avrobio, Inc. (AVRO) | 0.04% | $0.069B | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET) | 0.04% | $0.062B | N/A | N/A | N/A |
| Sorrento Therapeutics, Inc. (SRNE) | 0.03% | $0.056B | 31.10% | 36.24% | 5.16x |
| Dyadic International, Inc. (DYAI) | 0.03% | $0.055B | 27.12% | 5.28% | 13.23x |
| Solid Biosciences, Inc. (SLDB) | 0.03% | $0.052B | -100.00% | N/A | N/A |
| MediGene AG (MDG1) | 0.03% | N/A | 198.64% | 23.72% | 0.64x |
| Precision BioSciences, Inc. (DTIL) | 0.02% | $0.043B | 418.04% | 87.95% | -1.07x |
| Antisense Therapeutics Ltd. (ATHJF) | 0.02% | $0.041B | N/A | N/A | N/A |
| Passage Bio, Inc. (PASG) | 0.02% | $0.037B | N/A | N/A | N/A |
| Kraig Biocraft Laboratories, Inc. (KBLB) | 0.02% | $0.036B | N/A | N/A | N/A |
| Alaunos Therapeutics, Inc. (TCRT) | 0.02% | $0.034B | N/A | -38,225.00% | 36.07x |
| Sio Gene Therapies, Inc. (SIOX) | 0.02% | $0.028B | N/A | N/A | N/A |
| Regulus Therapeutics, Inc. (RGLS) | 0.01% | $0.026B | N/A | N/A | N/A |
| Gensight Biologics SA (GSGTF) | 0.01% | N/A | -51.06% | N/A | 61.12x |
| Evogene Ltd. (EVGN) | 0.01% | N/A | 128.53% | -69.42% | 19.09x |
| Amyris, Inc. (AMRS) | 0.01% | $0.021B | -2.82% | -1.52% | 5.73x |
| Vascular Biogenics Ltd. (VBLT) | 0.01% | $0.017B | -100.00% | N/A | -12.96x |
| Mustang Bio, Inc. (MBIO) | 0.01% | $0.017B | N/A | N/A | N/A |
| AquaBounty Technologies, Inc. (AQB) | 0.01% | $0.017B | -26.29% | -448.64% | -3.69x |
| Senti Biosciences, Inc. (SNTI) | 0.01% | $0.021B | -31.00% | -29.24% | 1.57x |
| Evolva Holding SA (EVE) | 0.01% | N/A | 57.32% | -57.22% | 6.29x |
| Celyad Oncology SA (CYAD) | 0.01% | N/A | N/A | N/A | N/A |
| BacTech Environmental Corp. (BAC) | 0.01% | N/A | N/A | N/A | N/A |
| Willow Biosciences, Inc. (CANSF) | <0.01% | N/A | -48.47% | N/A | 10.12x |
| Benitec Biopharma, Inc. (BNTC) | <0.01% | $0.008B | N/A | -1,100.00% | 63.23x |
| SeqLL, Inc. (SQL) | <0.01% | $0.007B | -100.00% | N/A | N/A |
| Arcadia Biosciences, Inc. (RKDA) | <0.01% | $0.005B | -64.00% | 29.37% | -2.05x |
| Bio-Path Holdings, Inc. (BPTH) | <0.01% | $0.004B | N/A | N/A | N/A |
| Cult Food Science Corp. (CULT) | <0.01% | N/A | N/A | N/A | N/A |
| Yield10 Bioscience, Inc. (YTEN) | <0.01% | $0.004B | -100.00% | N/A | 53.58x |
| Phio Pharmaceuticals Corp. (PHIO) | <0.01% | $0.003B | N/A | N/A | N/A |
| Bellicum Pharmaceuticals, Inc. (BLCM) | <0.01% | $0.003B | N/A | N/A | 20.62x |
| NeuBase Therapeutics, Inc. (NBSE) | <0.01% | $0.002B | N/A | N/A | N/A |
| Eat & Beyond Global Holdings, Inc. (EATS) | <0.01% | N/A | N/A | N/A | 0.91x |
Market data by FactSet
